ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2020
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy.
Abstract readLetterMulticenter Study
In one paragraph
Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials.Frontiers in pharmacology · 2022Pooled it
- Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries.Psoriasis (Auckland, N.Z.) · 2024Article
- Dermatology Publications on COVID-19 during the First Pandemic Year: Creativity or Opportunism?Life (Basel, Switzerland) · 2023Article
- Management of Infections in Psoriatic Patients Treated with Systemic Therapies: A Lesson from the Immunopathogenesis of Psoriasis.Dermatology practical & conceptual · 2023Review
- Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation?International journal of molecular sciences · 2022Review
- Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo.Vaccines · 2022Article
- Relationship between Immune Cells, Depression, Stress, and Psoriasis: Could the Use of Natural Products Be Helpful?Molecules (Basel, Switzerland) · 2022Review
- Letter to the editor regarding the article "Oguz Topal I, Kara Polat A, Zindancı İ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study. J Cosmet Dermatol. 2021;10.1111/jocd.14610."Journal of cosmetic dermatology · 2022Article
- Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease.Biomedicines · 2022Review
- Safety of SARS-CoV-2 vaccines in psoriatic patients treated with biologics: A real life experience.Dermatologic therapy · 2022Article
- Patient Preference for Biologic Treatments of Psoriasis in the Chinese Setting.Patient preference and adherence · 2022Article
- Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.Journal of clinical medicine · 2021Review
- Single-center survey of biologic use for inflammatory skin diseases during the coronavirus disease 2019 pandemic.The Journal of dermatology · 2021Article
- Mental Health Consequences of the COVID-19 Pandemic Long-Term Exposure in Italian Dermatologists.International journal of environmental research and public health · 2021Article
- Influence of SARS-CoV-2 Virus Infection on the Course of Psoriasis during Treatment with Biological Drugs.Medicina (Kaunas, Lithuania) · 2021Observational
- How does COVID-19 impact psoriasis practice, prescription patterns, and healthcare delivery for psoriasis patients? A cross-sectional survey study.Journal of cosmetic dermatology · 2021Observational
- Biologics for Psoriasis during the COVID-19 Pandemic.Journal of clinical medicine · 2021Review
- Dermatologists' attitude towards psoriasis treatment during the COVID-19 pandemic.Drugs in context · 2021Article
- The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments.Vaccines · 2020Review
- COVID-19: The Italian experience.Clinics in dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
37 authors.
M TalamontiDermatology Department, University of Rome 'Tor Vergata', Rome, Italy.
M GalluzzoDermatology Department, University of Rome 'Tor Vergata', Rome, Italy.
A ChiricozziDermatologia, Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
P QuaglinoMedical Sciences Department, Dermatologic Clinic, University of Turin, Turin, Italy.
G FabbrociniSection of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
P GisondiSection of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
A V MarzanoDermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
C PotenzaDepartment of Medico-Surgical Sciences and Biotechnologies, Dermatology Unit 'Daniele Innocenzi' Sapienza University of Rome - Polo Pontino, Rome, Italy.
A ContiDermatologic Unit, Department of Specialized Medicine, AOU Policlinico di Modena, Modena, Italy.
A ParodiOspedale-Policlinico San Martino IRCCS Genova, Clinica Dermatologica DiSSal Università di Genova, Genova, Italy.
A Belloni FortinaDermatology Unit - Department of Medicine DIMED, University of Padova, Padova, Italy.
F BardazziDermatology Division, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy.
G ArgenzianoDermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
F RongiolettiSection of Dermatology, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
L StingeniDermatology Section, Department of Medicine, University of Perugia, Perugia, Italy.
G MicaliDermatology Clinic, University of Catania, Catania, Italy.
F LoconsoleDepartment of Biomedical Science and Human Oncology, Unit of Dermatology, University of Bari, Bari, Italy.
M VenturiniDepartment of Dermatology, ASST Spedali Civili of Brescia, University of Brescia, Brescia, Italy.
M R BongiornoSection of Dermatology, Department of Health Promotion, Maternal-Infant, Internal Medicine and Specialization, University of Palermo, Palermo, Italy.
C FelicianiDepartment of Medicine and Surgery, Section of Dermatology, University of Parma, Parma, Italy.
P RubegniDermatology Unit, Department of Medical, Surgical and Neurosciences, University of Siena, Italy.
P AmerioDepartment of Medicine and Aging Science, Dermatologic Clinic, G. D'Annunzio University, Chieti, Italy.
M C FargnoliDermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
P PigattoDepartment of Biomedical, Surgical and Dental Sciences, Clinical Dermatology, IRCCS Galeazzi Orthopaedic Institute, University of Milan, Milan, Italy.
P SavoiaDepartment of Health Science, Dermatologic Clinic, University of Eastern Piedmont, Novara, Italy.
S P NisticòDermatology Unit, Department of Health Sciences, Università Magna Graecia, Catanzaro, Italy.
S GiustiniDepartment of Dermatology, Sapienza' University of Rome, Rome, Italy.
A CarugnoDermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.
S P CannavòDermatology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
G RechDivision of Dermatology, Santa Chiara Hospital, Trento, Italy.
F PrignanoDermatology Clinic, Department of Health Sciences, University of Florence, Florence, Italy.
A OffidaniDermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of the Marche Region, Ancona, Italy.
M LombardoUnit of Dermatological Diseases, ASST Sette Laghi, Ospedale di Circolo, Varese, Italy.
I ZalaudekDepartment of Dermatology, University of Trieste, Trieste, Italy.
L BianchiDermatology Department, University of Rome 'Tor Vergata', Rome, Italy.
K PerisDermatologia, Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
PSO-BIO-COVID study group
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Biological TherapyCOVID-19Chronic DiseaseEmergenciesHumansItalyPsoriasis
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.